Angiography-Derived FFR: Complicated Software or Imminent Reality?

Angiography-derived fractional flow reserve (FFR) demonstrated substantial usefulness, especially in patients with three-vessel lesions. The functional SYNTAX score derived from angiography has the potential to redefine prognosis and treatment strategies compared with the classic anatomical SYNTAX score.

Severidad de una lesión valorada con FFRThis study sought to investigate the applicability of this method in patients with multivessel lesions included in the SYNTAX II trial and to prove the usefulness of the functional score (as opposed to the anatomical score featured in the first SYNTAX trial).

 

All lesions assessed with instantaneous wave-free ratio (iFR) and/or FFR in the SYNTAX II trial were retrospectively analyzed to determine the feasibility of angiography-derived functional assessment.


Read also: Asymptomatic Coronary Artery Disease, Silent Ischemia: A Cardiologist’s Headache.


Patients analyzed with angiography-derived FFR were stratified according to its result, assessing their 2-year clinical prognosis.

 

The software was able to analyze 71% of the lesions, and its diagnostic performance to predict binary ischemia was substantial compared with FFR or iFR (area under the curve: 0.81; accuracy: 73.8%) with a positive predictive value of 85.9%.

 

The factors that interfered with its precision were lesions in side branches, bifurcation lesions, or small vessels.


Read also: Abluminal Sirolimus and luminal CD34 antibody layer: Is COMBO the Future of Stents?


According to the 2-year combined endpoint, the angiography-derived functional assessment reclassified 26.1% of the patients in high/intermediate risk group into low risk group appropriately.

 

The area under the curve for the angiography-derived functional assessment predicting 2-year events was higher than that of the classic anatomical SYNTAX score (0.68 vs. 0.56; p = 0.002).

 

Original title: Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial. Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived from Quantitative Flow Ratio in Patients with 3-Vessel Disease.

Reference: Taku Asano et al. Am Coll Cardiol Intv 2019;12:259–70.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...